BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 19768385)

  • 1. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis.
    Zhang Y; Yang H; Xiao B; Wu M; Zhou W; Li J; Li G; Christadoss P
    Mol Immunol; 2009 Feb; 46(4):657-67. PubMed ID: 19038457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-bet deficiency decreases susceptibility to experimental myasthenia gravis.
    Liu R; Hao J; Dayao CS; Shi FD; Campagnolo DI
    Exp Neurol; 2009 Dec; 220(2):366-73. PubMed ID: 19818352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
    Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
    J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice.
    Xin N; Fu L; Shao Z; Guo M; Zhang X; Zhang Y; Dou C; Zheng S; Shen X; Yao Y; Wang J; Wang J; Cui G; Liu Y; Geng D; Xiao C; Zhang Z; Dong R
    Mol Cell Neurosci; 2014 Jan; 58():85-94. PubMed ID: 24361642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis.
    Mu L; Sun B; Kong Q; Wang J; Wang G; Zhang S; Wang D; Liu Y; Liu Y; An H; Li H
    Immunology; 2009 Sep; 128(1 Suppl):e826-36. PubMed ID: 19740344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis.
    Yu S; Han B; Liu S; Wang H; Zhuang W; Huang Y; Zhang R
    Mol Immunol; 2017 Oct; 90():172-181. PubMed ID: 28802126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
    J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
    Li X; Zhang M; Wang B; Li Y; Wang L; Zhao X; Zhou X; Guo Y; Jiang G; Yao C
    J Ethnopharmacol; 2013 Dec; 150(3):907-17. PubMed ID: 24140602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalances in T Cell-Related Transcription Factors Among Patients with Hashimoto's Thyroiditis.
    Safdari V; Alijani E; Nemati M; Jafarzadeh A
    Sultan Qaboos Univ Med J; 2017 May; 17(2):e174-e180. PubMed ID: 28690889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
    Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
    J Neuroinflammation; 2016 Jan; 13():8. PubMed ID: 26757900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells.
    Sheng JR; Li L; Ganesh BB; Vasu C; Prabhakar BS; Meriggioli MN
    J Immunol; 2006 Oct; 177(8):5296-306. PubMed ID: 17015715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
    Aricha R; Reuveni D; Fuchs S; Souroujon MC
    J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral-mediated shRNA against RelB induces the generation of tolerogenic dendritic cells.
    Qiu T; Zhu HC; Liu XH; Dong WC; Weng XD; Hu CH; Kuang YL; Gao RH; Dan C; Tao T
    Int Immunopharmacol; 2012 Mar; 12(3):501-9. PubMed ID: 22266276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.
    Schaffert H; Pelz A; Saxena A; Losen M; Meisel A; Thiel A; Kohler S
    Eur J Immunol; 2015 May; 45(5):1339-47. PubMed ID: 25676041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
    Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
    J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.